Join Karen Chagin, MD, SVP of Early-Stage Development, as she gives advice to those aspiring to a career in oncology or early-stage drug development, particularly in the cell therapy space, based on her journey. #CareerAdvice #EarlyStageDevelopment #CancerResearch
Adaptimmune
Biotechnology Research
Abingdon, Oxfordshire 45,752 followers
Designing and delivering cell therapies to transform the lives of people with cancer.
About us
Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page.
- Website
-
http://www.adaptimmune.com
External link for Adaptimmune
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Abingdon, Oxfordshire
- Type
- Public Company
- Founded
- 2008
Locations
-
Primary
Get directions
60 Jubilee Avenue
Milton Park
Abingdon, Oxfordshire OX14 4RX, GB
-
Get directions
351 Rouse Boulevard
Philadelphia, Pennsylvania 19112, US
-
Get directions
100 Binney St
Suite 710
Cambridge, Massachusetts 02142, US
Employees at Adaptimmune
Updates
-
#SarcomaAwarenessMonth This month, we join the global sarcoma community in raising awareness for synovial sarcoma, a rare and aggressive form of cancer that primarily affects young adults in the prime of their lives. Learn more at curesarcoma.org and sarcomaalliance.org #SarcomaAwareness #Biotech #Innovation #Oncology #CancerCare
-
-
Take a deeper look into the science of T-cell therapy at Adaptimmune. Our technology enhances T-cell receptors to target cancer cells more effectively! Learn more at: www.adaptimmune.com #ScienceOfHealing #EngineeringHope #CancerBreakthrough
-
-
Join Karen Chagin, MD, SVP of Early-Stage Development, as she discusses the patient journey and how each experience is unique. #EarlyStageDevelopment #CancerResearch https://bit.ly/3Kx80p2
-
What is the potential role of TCR T-cells in cancer therapies? Learn more @ www.adaptimmune.com #CancerTherapy #HealthcareInnovation
-
-
Join Karen Chagin, MD, SVP of Early-Stage Development, as she explores the challenges faced in the development of early-stage T-cell therapies. #EarlyStageDevelopment #CancerResearch https://bit.ly/4aQlIhh
-
Every cancer journey is unique and so are our engineered TCR T-cell therapies.. Learn more about how we use each patient’s own cells to fight their cancer, offering a more targeted approach to treatment. #TCellTherapy #CancerResearch #HealthInnovation https://bit.ly/4e4CqMZ
-
-
At Adaptimmune, we're harnessing cutting-edge cell therapy to redefine cancer treatment. Our TCR T-cell therapies are specifically designed to target and combat the most challenging solid tumor cancers. #CellTherapy #CancerTreatment #Innovation https://bit.ly/4e4CqMZ
-
-
Join Karen Chagin, MD, SVP of Early-Stage Development, as she discusses her role at Adaptimmune and how she is helping shape the future of T-cell therapy. #EarlyStageDevelopment #CancerResearch https://bit.ly/4e4CqMZ
-
🌈 Happy Pride Month! We celebrate diversity and inclusivity every day. Join us in celebrating love, acceptance, and the unique qualities that make each of us who we are. Together, let's continue to foster a culture of belonging and support for all. #PrideMonth #InclusiveHealthcare #PrideIsForEveryone #Adaptimmune #Pride2024
-